DK153124C - Fremgangsmaade til fremstilling af et stabilt toerpraeparat af et alkalimetalsalt af dehydroepiandrosteronsulfat, som er beregnet til parenteral administration - Google Patents

Fremgangsmaade til fremstilling af et stabilt toerpraeparat af et alkalimetalsalt af dehydroepiandrosteronsulfat, som er beregnet til parenteral administration

Info

Publication number
DK153124C
DK153124C DK396576A DK396576A DK153124C DK 153124 C DK153124 C DK 153124C DK 396576 A DK396576 A DK 396576A DK 396576 A DK396576 A DK 396576A DK 153124 C DK153124 C DK 153124C
Authority
DK
Denmark
Prior art keywords
alkalimal
dehydroepiandrosteron
preparing
procedure
metal salt
Prior art date
Application number
DK396576A
Other languages
English (en)
Other versions
DK396576A (da
DK153124B (da
Inventor
Isao Sugimoto
Yoko Sawase
Original Assignee
Kanebo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP50108197A external-priority patent/JPS5231821A/ja
Priority claimed from JP8061376A external-priority patent/JPS537662A/ja
Application filed by Kanebo Ltd filed Critical Kanebo Ltd
Publication of DK396576A publication Critical patent/DK396576A/da
Publication of DK153124B publication Critical patent/DK153124B/da
Application granted granted Critical
Publication of DK153124C publication Critical patent/DK153124C/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
DK396576A 1975-09-05 1976-09-02 Fremgangsmaade til fremstilling af et stabilt toerpraeparat af et alkalimetalsalt af dehydroepiandrosteronsulfat, som er beregnet til parenteral administration DK153124C (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP50108197A JPS5231821A (en) 1975-09-05 1975-09-05 Method of manufacturing freeze-dried dehydroepiandrosterone sulfate sa lts for injection use
JP10819775 1975-09-05
JP8061376 1976-07-06
JP8061376A JPS537662A (en) 1976-07-06 1976-07-06 Preparation of injection containing stable dehydroepiandrosterone sulfate

Publications (3)

Publication Number Publication Date
DK396576A DK396576A (da) 1977-03-06
DK153124B DK153124B (da) 1988-06-20
DK153124C true DK153124C (da) 1988-12-19

Family

ID=26421606

Family Applications (1)

Application Number Title Priority Date Filing Date
DK396576A DK153124C (da) 1975-09-05 1976-09-02 Fremgangsmaade til fremstilling af et stabilt toerpraeparat af et alkalimetalsalt af dehydroepiandrosteronsulfat, som er beregnet til parenteral administration

Country Status (15)

Country Link
US (1) US4061744A (da)
AU (1) AU498543B2 (da)
CA (1) CA1047404A (da)
CS (1) CS216160B2 (da)
DD (1) DD127381A5 (da)
DE (1) DE2639849C2 (da)
DK (1) DK153124C (da)
ES (1) ES451256A1 (da)
FR (1) FR2322605A1 (da)
GB (1) GB1561360A (da)
HU (1) HU173475B (da)
IL (1) IL50376A (da)
NL (1) NL183385C (da)
SE (1) SE439586B (da)
SU (1) SU1072789A3 (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4496556A (en) * 1982-08-16 1985-01-29 Norman Orentreich Topical applications for preventing dry skin
JPS63104924A (ja) * 1986-10-20 1988-05-10 Kanebo Ltd 膣坐剤
NL194728C (nl) * 1987-04-16 2003-01-07 Hollis Eden Pharmaceuticals Farmaceutisch preparaat geschikt voor de profylaxe of therapie van een retrovirale infectie of een complicatie of gevolg daarvan.
JPS6440428A (en) * 1987-08-07 1989-02-10 Daiichi Yakuhin Sangyo Kk Antihyperlipemia
US5246704A (en) * 1989-01-23 1993-09-21 Kanebo, Ltd. Vaginal suppository
JP2546808B2 (ja) * 1989-01-23 1996-10-23 鐘紡株式会社 膣坐剤
US5004651A (en) * 1989-01-24 1991-04-02 Abbott Laboratories Stabilizing system for solid dosage forms
CA2013474C (en) * 1989-04-20 2000-01-18 Pharmacia Inc. Cyclophosphamide - alanine lyophilizates
US5268368A (en) * 1991-05-17 1993-12-07 Erbamont, Inc. Cyclophosphamide--amino acid lyophilizates
US5210081A (en) * 1992-02-26 1993-05-11 American Home Products Corporation Alkali metal 8,9-dehydroestrone sulfate esters

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB957392A (en) * 1961-07-17 1964-05-06 Farmaceutici Italia 16ª‡-hydroxy-steroids
DE1767898A1 (de) * 1967-07-28 1971-09-30 Hoffmann La Roche Verfahren zur Herstellung einer Arzneimittelzubereitung
US4005200A (en) * 1975-07-17 1977-01-25 Kanebo, Ltd. Method for improving the maturity of the parturient canal and the sensitivity to oxytocin

Also Published As

Publication number Publication date
GB1561360A (en) 1980-02-20
IL50376A0 (en) 1976-10-31
SU1072789A3 (ru) 1984-02-07
US4061744A (en) 1977-12-06
SE439586B (sv) 1985-06-24
DK396576A (da) 1977-03-06
DE2639849C2 (de) 1987-02-12
ES451256A1 (es) 1977-09-16
IL50376A (en) 1979-10-31
NL183385C (nl) 1988-10-17
AU498543B2 (en) 1979-03-15
DE2639849A1 (de) 1977-03-17
HU173475B (hu) 1979-05-28
CA1047404A (en) 1979-01-30
SE7609443L (sv) 1977-03-06
DK153124B (da) 1988-06-20
CS216160B2 (en) 1982-10-29
AU1748676A (en) 1978-03-16
FR2322605B1 (da) 1982-08-20
DD127381A5 (da) 1977-09-21
NL7609833A (nl) 1977-03-08
FR2322605A1 (fr) 1977-04-01
NL183385B (nl) 1988-05-16

Similar Documents

Publication Publication Date Title
DK298176A (da) Fremgangsmade til fremstilling af 1,4-dihydropyrinderivater
DK584676A (da) Fremgangsmade til fremstilling af et stabilt antibiotisk preparat
DK494876A (da) Fremgangsmade til fremstilling af piperidinderivater
DK235876A (da) Fremgangsmade til fremstilling af thienopyridinderivater
DK518176A (da) Fremgangsmade til fremstilling af polyprenylderivater
DK301876A (da) Fremgangsmade til fremstilling af et lactuloseholdigt pulver
DK143407C (da) Fremgangsmaade til fremstilling af et stift polyurinstofskum
DK562376A (da) Fremgangsmade til fremstilling af ergolinderivater
DK462376A (da) Fremgangsmade til fremstilling af 5-halogenpyrimidinderivater
DK415676A (da) Fremgangsmade til fremstilling af pilocarpiniumsalte
DK361078A (da) Fremgangsmaade til fremstilling af en krystallinsk form af natriumsaltet af et oximderivat af 7-aminothiazolylacetamidocephalosporansyre
DK153124C (da) Fremgangsmaade til fremstilling af et stabilt toerpraeparat af et alkalimetalsalt af dehydroepiandrosteronsulfat, som er beregnet til parenteral administration
DK344076A (da) Fremgangsmade til fremstilling af thienopyridinderivater
DK29376A (da) Fremgangsmade til fremstilling af 1-aryloxy-3-n-substituerede aminopropanderivater
DK149194C (da) Fremgangs-maade til fremstilling af (r)-n-phenylalaninderivater
DK98076A (da) Fremgangsmade til fremstilling af et farmaceutisk preparat
DK20077A (da) Fremgangsmade til fremstilling af salte af 3,3-dimethyl-2-oxo-smorsyre
DK372177A (da) Fremgangsmaade til fremstilling af thiophenderivater
DK362676A (da) Fremgangsmade til fremstilling af 1,4-dihydropyridiner
DK146540C (da) Fremgangsmaade til fremstilling af alkaloider af leurosin-typen, eller syreadditionssalte deraf
DK531676A (da) Fremgangsmade til fremstilling af ethylaminderivater
DK390976A (da) Fremgangsmade til fremstilling af o,o-dialkylthinophosphorsyrechlorider
DK157600C (da) Fremgangsmaade til fremstilling af en stabil, overmaettet, vandig isosorbiddinitratoploesning
DK143905C (da) Analogifremgangsmaade til fremstilling af fusidinsyrederivater
DK140576A (da) Fremgangsmade til fremstilling af 21-hydroxy-16-pregnen-20-on-derivater

Legal Events

Date Code Title Description
PUP Patent expired